A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101

Jelinek, Michael J., Foster, Nathan R., Zoroufy, Alex J. · Oral Oncology · 2021